Att. 2_60-day Published FRN

5124

Federal Register / Vol. 81, No. 20 / Monday, February 1, 2016 / Notices

Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In 2012, the most recent year for
which complete information is
available, more than 580,000 people
died of cancer and more than 1.5
million were diagnosed with cancer. It
is estimated that 13.8 million Americans
are currently alive with a history of
cancer (2). In the U.S., state-based
cancer registries are the only method for
systematically collecting and reporting
population based information about
cancer incidence and outcomes such as
survival. These data are used to measure
the changing incidence and burden of
each cancer; identify populations at
increased or increasing risk; target
preventive measures; and measure the
success or failure of cancer control
efforts in the U.S.
In 1992, Congress passed the Cancer
Registries Amendment Act which
established the National Program of
Cancer Registries (NPCR). The NPCR
provides support for state-based cancer
registries that collect, manage and
analyze data about cancer cases. The
state-based cancer registries report
information to CDC through the
National Program of Cancer Registries
Cancer Surveillance System (NPCR
CSS), (OMB No. 0920–0469 5/31/2016).
CDC plans to request OMB approval to
continue collecting this information for

data elements specified for the Standard
NPCR CSS Report. Ten specialized
CCRs submit data elements specified for
the Enhanced NPCR CSS Report, which
includes additional information about
treatment and follow-up for cases of
breast, colorectal, and chronic myeloid
leukemia cases diagnosed in 2011. Each
CCR is asked to transmit two data files
to CDC per year. The first file, submitted
in January, is a preliminary report
consisting of one year of data for the
most recent year of available data. CDC
evaluates the preliminary data for
completeness and quality and provides
a report back to the CCR. The second
file, submitted by November, contains
cumulative cancer incidence data from
the first diagnosis year for which the
cancer registry collected data with the
assistance of NPCR funds (e.g., 1995)
through 12 months past the close of the
most recent diagnosis year (e.g., 2014).
The cumulative file is used for analysis
and reporting.
The burden for each file transmission
is estimated at two hours per response.
Because cancer incidence data are
already collected and aggregated at the
state level the additional burden of
reporting the information to CDC is
small.
All information is transmitted to CDC
electronically. Participation is required
as a condition of the cooperative
agreement with CDC. There are no costs
to respondents except their time.

three years. Data definitions will be
updated to reflect changes in national
standards for cancer diagnosis and
coding, but the number of respondents
and the burden per respondent will not
change.
The NPCR CSS allows CDC to collect,
aggregate, evaluate and disseminate
cancer incidence data at the national
level. The NPCR CSS is the primary
source of information for United States
Cancer Statistics (USCS), which CDC
has published annually since 2002. The
latest USCS report published in 2015
provided cancer statistics for 99% of the
United States population from all cancer
registries whose data met national data
standards. Prior to the publication of
USCS, cancer incidence data at the
national level were available for only
14% of the population of the United
States.
The NPCR CSS also allows CDC to
monitor cancer trends over time,
describe geographic variation in cancer
incidence throughout the country, and
provide incidence data on racial/ethnic
populations and rare cancers. These
activities and analyses further support
CDC’s planning and evaluation efforts
for state and national cancer control and
prevention. In addition, datasets can be
made available for secondary analysis.
Respondents are NPCR-supported
central cancer registries (CCR) in 45 U.S.
states, 2 territories, and the District of
Columbia. Thirty-eight CCRs submit

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Central Cancer Registries in States, Territories and the District of Columbia.

Standard NPCR CSS Report
Enhanced NPCR CSS Report.

38
10

2
2

2
2

152
40

Total .......................................................

...............................................

........................

........................

........................

192

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2016–01723 Filed 1–29–16; 8:45 am]

[60Day–16–16LL; Docket No. CDC–2016–
0012]

BILLING CODE 4163–18–P

rmajette on DSK2TPTVN1PROD with NOTICES

Number of
respondents

Type of respondents

Centers for Disease Control and
Prevention

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

ACTION:

VerDate Sep<11>2014

15:33 Jan 29, 2016

Jkt 238001

PO 00000

Notice with comment period.

Frm 00032

Fmt 4703

Sfmt 4703

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collect project entitled ‘‘Evaluation of
Enhancing HIV Prevention
Communication and Mobilization
Efforts through Strategic Partnerships’’.

SUMMARY:

E:\FR\FM\01FEN1.SGM

01FEN1

Federal Register / Vol. 81, No. 20 / Monday, February 1, 2016 / Notices
Written comments must be
received on or before April 1, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0012 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
DATES:

Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.

rmajette on DSK2TPTVN1PROD with NOTICES

FOR FURTHER INFORMATION CONTACT:

To

request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information

VerDate Sep<11>2014

15:33 Jan 29, 2016

Jkt 238001

on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Evaluation of Enhancing HIV
Prevention Communication and
Mobilization Efforts through Strategic
Partnerships—New—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In an effort to refocus attention on
domestic HIV and AIDS, CDC launched
the Act Against AIDS (AAA) initiative
in 2009 with the White House and the
U.S. Department of Health and Human
Services. AAA is a multifaceted national
communication initiative that supports
reduction of HIV incidence in the U.S.
through multiple, concurrent
communication and education
campaigns for a variety of audiences
including, the general public,
populations most affected by HIV and
health care providers. All campaigns
support the comprehensive HIV
prevention efforts of CDC and the
National HIV/AIDS Strategy (NHAS).
Within this context, the CDC’s
Division of HIV/AIDS Prevention
(DHAP) is implementing various
partnership activities to increase HIV
awareness among the general public,
reduce new HIV infections among
disproportionately impacted
populations, and improve health
outcomes for people living with HIV
and AIDS in the United States and its
territories.
For example, DHAP is funding the
‘‘Enhancing HIV Prevention
Communication and Mobilization
Efforts through Strategic Partnerships’’
program. Partners funded under the

PO 00000

Frm 00033

Fmt 4703

Sfmt 4703

5125

partnership program will (1) support the
dissemination of Act Against AIDS
(AAA) campaign materials, messaging,
and other CDC resources that support
HIV prevention and (2) implement
national engagement efforts focusing on
HIV prevention and awareness. Partners
represent civil, media, and LGBTfocused organizations.
In addition, DHAP will continue to
support the Business Responds to AIDS
(BRTA) program. Founded in 1992, the
purpose of the BRTA program is to
engage and support the private sector in
promoting HIV education, awareness,
and policies in the workplace. This
partnership between CDC, business,
labor, and the public health sector aims
to encourage businesses to implement
HIV/AIDS policies and education
programs in the workplace with the
overarching goal of increasing public
understanding of, involvement in, and
support for HIV prevention. Other
partnership efforts serve the same
purpose: To increase HIV awareness
among the general public, reduce new
HIV infections among
disproportionately impacted
populations, and improve health
outcomes for people living with HIV
and AIDS in the United States and its
territories.
The project will evaluate the extent to
which activities implemented by
partners meet the initiative’s goals for
disseminating, communicating, and
engaging the public in HIV prevention
and education activities. We will collect
information from partners on their
activities for disseminating HIV
messages through materials distribution
at national and local events, media and
advertising, HIV testing facilitation, and
formation and coordination of strategic
partnerships; barriers and facilitators to
implementation of these activities, and
factors that may help contextualize their
progress towards meeting the initiative’s
goals; and their involvement in
promoting HIV education, awareness,
and policies in their organization. We
will collect this information through
these five sources: (a) Metrics Database:
Partners will be required to report
quarterly data to CDC and CDC’s
evaluation contractor through a metrics
database. (b) Biannual key informant
interviews: The point of contacts from
some partner organizations will be
interviewed twice yearly via telephone.
(c) Interim Progress Reports: Partners
will complete a standardized progress
report on a biannual basis via a userfriendly electronic form. The progress
reports will gather information on key
successes, facilitators and barriers, and
major achievements. (d) Partner Survey:
Partners will complete a brief online

E:\FR\FM\01FEN1.SGM

01FEN1

5126

Federal Register / Vol. 81, No. 20 / Monday, February 1, 2016 / Notices

survey to assess their involvement in
promoting HIV education, awareness,
and policies in their organization. (e)
Partnerships Activities Form: Partners
may be asked to complete a brief
electronic form to provide information
on each partner activity that they
complete. The form will collect
information on information such as the
type of event, the audience, and key

The information obtained from the
proposed study will be used by federal
policy makers to assess the effectiveness
of the partnership activities and the
appropriateness of continued or
expanded funding of partnership
projects.
There is no cost to participants other
than their time. The total estimated
annualized burden hours are 5,200.

highlights; the number of HIV tests
administered (if any) and the number of
preliminary positives; the number and
type of materials distributed. This
information will allow CDC to know
what partners are doing to advance HIV
prevention and education, and how
CDC can alter their partnership efforts to
facilitate HIV prevention and education
in the future.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent

Partner
Partner
Partner
Partner
Partner

Organization
Organization
Organization
Organization
Organization

Average
burden per
response
(in hours)

Total
burden
hours

.........................
.........................
.........................
.........................
.........................

Quarterly Metric Database ...............
Bi-annual Key Informant Interview ..
Interim Progress Reports .................
Partner Survey .................................
Partnerships Activities Form ............

50
25
25
300
500

4
2
2
1
4

18
1
8
30/60
25/60

3,600
50
400
150
1,000

Total ...........................................

..........................................................

........................

........................

........................

5,200

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–01721 Filed 1–29–16; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–16CO]

Agency Forms Undergoing Paperwork
Reduction Act Review

rmajette on DSK2TPTVN1PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Form name

The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of

VerDate Sep<11>2014

15:33 Jan 29, 2016

Jkt 238001

the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Developing a Self-Management Tool
for Individuals with Systemic Lupus
Erythematosus—New—National Center
for Chronic Disease Preventions and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Systemic Lupus Erythematosus (SLE)
is an autoimmune disease in which the
immune system produces antibodies to
cells within the body leading to
widespread inflammation and tissue
damage. SLE has a variety of clinical

PO 00000

Frm 00034

Fmt 4703

Sfmt 4703

manifestations and can affect joints,
skin, the brain, lungs, kidneys, and
blood vessels.
Effective SLE management depends
not only upon clinical interventions, but
also on self-management— those things
done on a day-to-day basis to manage
SLE. SLE self-management requires
gaining essential knowledge, skills, and
confidence to manage the condition.
CDC previously launched a two-year
project called ‘‘Filling a Gap: Creating
Educational Program, Tools, or
Materials to Enhance Self-Management
in Systemic Lupus Erythematosus’’ to
identify and address the needs of lupus
patients in practicing effective selfmanagement. The purpose of this
project is to develop a SLE selfmanagement tool to improve the ability
of people living with lupus to manage
their condition.
The proposed information collection
will assess a prototype CDC SLE selfmanagement tool that is in development
to ensure that the tool is usable and
useful to members of the target
audience. The tool is expected to be
comprised of multiple SLE selfmanagement resources that may
include, but are not limited to:
Education resources about fatigue
management, pain management, healthy
diet, and exercise; symptom trackers;
medication trackers; appointment
calendars; resources about
communication with family, friends,
and co-workers about SLE; and
strategies for coping with depression
and anxiety.
CDC plans to make the tool available
in an electronic format (web-based or a
native mobile application) and will

E:\FR\FM\01FEN1.SGM

01FEN1